These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21938494)

  • 1. S100-A10, thioredoxin, and S100-A6 as biomarkers of papillary thyroid carcinoma with lymph node metastasis identified by MALDI imaging.
    Nipp M; Elsner M; Balluff B; Meding S; Sarioglu H; Ueffing M; Rauser S; Unger K; Höfler H; Walch A; Zitzelsberger H
    J Mol Med (Berl); 2012 Feb; 90(2):163-74. PubMed ID: 21938494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide Profile Differences of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features, Encapsulated Follicular Variant, and Classical Papillary Thyroid Carcinoma: An Application of Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging.
    Ucal Y; Tokat F; Duren M; Ince U; Ozpinar A
    Thyroid; 2019 Aug; 29(8):1125-1137. PubMed ID: 31064269
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue.
    Brown LM; Helmke SM; Hunsucker SW; Netea-Maier RT; Chiang SA; Heinz DE; Shroyer KR; Duncan MW; Haugen BR
    Mol Carcinog; 2006 Aug; 45(8):613-26. PubMed ID: 16788983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cell and bulk RNA sequencing reveal heterogeneity and diagnostic markers in papillary thyroid carcinoma lymph-node metastasis.
    Lu DN; Zhang WC; Lin YZ; Jiang HY; He R; Li SL; Zhang YN; Shao CY; Zheng CM; Xu JJ; Ge MH
    J Endocrinol Invest; 2024 Jun; 47(6):1513-1530. PubMed ID: 38146045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-based proteomics reveals FXYD3, S100A11 and GSTM3 as novel markers for regional lymph node metastasis in colon cancer.
    Meding S; Balluff B; Elsner M; Schöne C; Rauser S; Nitsche U; Maak M; Schäfer A; Hauck SM; Ueffing M; Langer R; Höfler H; Friess H; Rosenberg R; Walch A
    J Pathol; 2012 Dec; 228(4):459-70. PubMed ID: 22430872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples.
    Lin P; Yao Z; Sun Y; Li W; Liu Y; Liang K; Liu Y; Qin J; Hou X; Chen L
    J Proteomics; 2019 Jul; 204():103414. PubMed ID: 31195151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MALDI imaging mass spectrometry reveals COX7A2, TAGLN2 and S100-A10 as novel prognostic markers in Barrett's adenocarcinoma.
    Elsner M; Rauser S; Maier S; Schöne C; Balluff B; Meding S; Jung G; Nipp M; Sarioglu H; Maccarrone G; Aichler M; Feuchtinger A; Langer R; Jütting U; Feith M; Küster B; Ueffing M; Zitzelsberger H; Höfler H; Walch A
    J Proteomics; 2012 Aug; 75(15):4693-704. PubMed ID: 22365974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymosin beta 10 correlates with lymph node metastases of papillary thyroid carcinoma.
    Zhang XJ; Su YR; Liu D; Xu DB; Zeng MS; Chen WK
    J Surg Res; 2014 Dec; 192(2):487-93. PubMed ID: 24974154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical levels of matrix metalloproteinase-2 and CD44 variant 6 protein in the diagnosis and lateral cervical lymph node metastasis of papillary thyroid carcinoma.
    Wu G; Zhou Y; Li T; Guo J; Zhou Z
    J Int Med Res; 2013 Jun; 41(3):816-24. PubMed ID: 23685894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of biomarkers associated with cervical lymph node metastasis in papillary thyroid carcinoma: Evidence from an integrated bioinformatic analysis.
    Zhang Z; Zhao S; Wang K; Shang M; Chen Z; Yang H; Chen Y; Chen B
    Clin Hemorheol Microcirc; 2021; 78(2):117-126. PubMed ID: 33554894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics for the diagnosis of thyroid lesions: preliminary report.
    Pagni F; Mainini V; Garancini M; Bono F; Vanzati A; Giardini V; Scardilli M; Goffredo P; Smith AJ; Galli M; De Sio G; Magni F
    Cytopathology; 2015 Oct; 26(5):318-24. PubMed ID: 25040579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging mass spectrometry in papillary thyroid carcinoma for the identification and validation of biomarker proteins.
    Min KW; Bang JY; Kim KP; Kim WS; Lee SH; Shanta SR; Lee JH; Hong JH; Lim SD; Yoo YB; Na CH
    J Korean Med Sci; 2014 Jul; 29(7):934-40. PubMed ID: 25045225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multiplexed, targeted mass spectrometry assay of the S100 protein family uncovers the isoform-specific expression in thyroid tumours.
    Martínez-Aguilar J; Clifton-Bligh R; Molloy MP
    BMC Cancer; 2015 Mar; 15():199. PubMed ID: 25880590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The expression and significance of trefoil factor 3 and SDF-1/CXCR4 biological axis in papillary thyroid carcinoma].
    Xue G; Huang J; Zhang H; Zhang W; Wu J; Shang X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jan; 28(2):108-12. PubMed ID: 24738314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular profiling of matched samples identifies biomarkers of papillary thyroid carcinoma lymph node metastasis.
    Cerutti JM; Oler G; Michaluart P; Delcelo R; Beaty RM; Shoemaker J; Riggins GJ
    Cancer Res; 2007 Aug; 67(16):7885-92. PubMed ID: 17699795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. REGγ Is Associated with Lymph Node Metastasis and T-Stage in Papillary Thyroid Carcinoma.
    Qi L; He W
    Med Sci Monit; 2018 Mar; 24():1373-1378. PubMed ID: 29509725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic study of thyroid tumors reveals frequent up-regulation of the Ca2+ -binding protein S100A6 in papillary thyroid carcinoma.
    Sofiadis A; Dinets A; Orre LM; Branca RM; Juhlin CC; Foukakis T; Wallin G; Höög A; Hulchiy M; Zedenius J; Larsson C; Lehtiö J
    Thyroid; 2010 Oct; 20(10):1067-76. PubMed ID: 20629554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive transcriptomic analysis of papillary thyroid cancer: potential biomarkers associated with tumor progression.
    Hosseinkhan N; Honardoost M; Blighe K; Moore CBT; Khamseh ME
    J Endocrinol Invest; 2020 Jul; 43(7):911-923. PubMed ID: 31965517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic and Phosphoproteomic analysis of thyroid papillary carcinoma: Identification of potential biomarkers for metastasis.
    Peng L; Zhang Z; Du W; Zhu J; Duan W
    J Proteomics; 2024 Aug; 306():105260. PubMed ID: 39029786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of MiR-431 expression associated with lymph node metastasis and promotes cell invasion in papillary thyroid carcinoma.
    Liu Y; Li L; Liu Z; Yuan Q; Lu X
    Cancer Biomark; 2018; 22(4):727-732. PubMed ID: 29945344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.